| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Cortexyme, Inc. | Director | Stock Option (right to buy) | 22,058 | 14 Mar 2022 | Direct | ||
| CervoMed Inc. | Director | Stock Option (Right to Buy) | 8,100 | 23 Jun 2025 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| CRVO | CervoMed Inc. | 23 Jun 2025 | 1 | $0 | 4 | Director | 25 Jun 2025, 17:02 |
| CRVO | CervoMed Inc. | 14 Jun 2024 | 1 | $0 | 4 | Director | 14 Jun 2024, 18:20 |
| DFFN | CervoMed Inc. | 15 Sep 2023 | 1 | $0 | 4 | Director | 15 Sep 2023, 18:53 |
| DFFN | CervoMed Inc. | 16 Aug 2023 | 0 | $0 | 3 | Director | 24 Aug 2023, 21:30 |
| QNCX | Cortexyme, Inc. | 14 Mar 2022 | 1 | $0 | 4 | Director | 16 Mar 2022, 18:33 |
| QNCX | Cortexyme, Inc. | 14 Mar 2022 | 0 | $0 | 3 | Director | 16 Mar 2022, 18:29 |